Related Experiment Video
Updated: May 20, 2025

Rapid Nanoprobe Signal Enhancement by In Situ Gold Nanoparticle Synthesis
Published on: March 7, 2018
Enhancing Candida auris diagnosis: a comprehensive evaluation of VIASURE Candida auris real-time PCR detection kit
Blanca Dehesa-García1, Henar Alonso2, María Paz Peris3
1Health Research Institute Aragón, Zaragoza, Spain.
Abstract:
Candida auris, a yeast that is highly resistant to antifungal treatments, represents a significant healthcare concern due to its rapid spread through surface contamination and patient colonization. A recent outbreak at the Miguel Servet University Hospital in Zaragoza, Spain, highlighted the urgent need for rapid diagnostic responses. The current 4-day duration for microbiological culture results hinders timely patient isolation and transmission prevention. This study aims to evaluate the VIASURE Candida auris Real-Time PCR Detection Kit (Certest Biotec) for diagnostic performance and analytical specificity compared to the standard methodology based on culture and MALDI-TOF MS characterization. From August 2023 to December 2023, the Microbiology Service of the Miguel Servet University Hospital processed 816 diagnostic samples. Accuracy testing resulted in adequate clinical validation values, as presented here: sensitivity, 0.98 (95% confidence interval [CI], 0.90 to 1); specificity, 1 (95% CI, 0.99 to 1); positive predictive value, 0.98 (95% CI, 0.90 to 1); and negative predictive value, 1 (95% CI, 0.99 to 1). The implementation of this molecular biology test in the laboratory promises to improve diagnostic efficiency by allowing rapid patient isolation, initiation of appropriate treatment, and effective isolation measures.
Importance:
Candida auris, a resilient and antifungal-resistant yeast, poses a significant healthcare threat due to its rapid spread. A recent outbreak at a hospital in Zaragoza, Spain, emphasized the urgent need for faster diagnostics. The current four-day wait for culture results hampers timely patient isolation. This retrospective and comparative study demonstrates the favorable clinical parameters of a commercially available molecular diagnostic kit. The kit allows enhanced diagnostic efficiency, swifter patient isolation, and more effective control measures in the laboratory. In conclusion, the kit addresses the pressing challenges presented by C. auris in healthcare.
Insights
A new real-time PCR kit for Candida auris (C. auris) offers rapid and accurate detection, improving patient isolation and treatment. This molecular test significantly speeds up diagnosis compared to traditional methods, enhancing infection control in hospitals.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Molecular Diagnostics
Background:
- Candida auris (C. auris) is a highly antifungal-resistant yeast causing significant healthcare concerns due to rapid spread and colonization.
- Current diagnostic methods relying on microbiological cultures take up to four days, delaying critical patient isolation and infection control measures.
- A recent hospital outbreak underscored the urgent need for rapid diagnostic tools to manage C. auris transmission.
Purpose of the Study:
- To evaluate the diagnostic performance and analytical specificity of the VIASURE Candida auris Real-Time PCR Detection Kit.
- To compare the molecular test's efficacy against standard culture and MALDI-TOF MS methodologies.
- To assess the potential of the PCR kit in improving diagnostic efficiency for C. auris.
Main Methods:
- A retrospective and comparative study was conducted at Miguel Servet University Hospital from August to December 2023.
- 816 diagnostic samples were processed using the VIASURE Candida auris Real-Time PCR Detection Kit.
- Performance was evaluated against standard culture and MALDI-TOF MS characterization, calculating sensitivity, specificity, and predictive values.
Main Results:
- The VIASURE Candida auris Real-Time PCR Detection Kit demonstrated high diagnostic accuracy.
- Sensitivity was 0.98 (95% CI, 0.90-1), specificity was 1 (95% CI, 0.99-1).
- Positive predictive value was 0.98 (95% CI, 0.90-1), and negative predictive value was 1 (95% CI, 0.99-1).
Conclusions:
- The VIASURE Candida auris Real-Time PCR Detection Kit offers favorable clinical validation and analytical specificity.
- Implementation of this molecular test can significantly enhance diagnostic efficiency in clinical laboratories.
- Rapid detection facilitates quicker patient isolation, timely treatment initiation, and effective control of C. auris outbreaks.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Long-term Potentiation
Hebbian LTP
LTP can occur when...
Self-Evaluation: Self-Enhancement and Self-Verification
Social Facilitation
Elaborative Rehearsals
The effectiveness of...
Allosteric Regulation

